Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Chronic inflammatory demyelinating polyneuropathy

Launch
Not announced
Last updated
143 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Care management intervention strategies

5 evidence topics · 12 sources

Immunoglobulin dose optimization and cessation trials
Home and subcutaneous administration
Outcome monitoring with disability, strength, and patient-reported scales